RT Journal Article
SR Electronic
T1 Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka <em>et al</em>
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP e172
OP e172
DO 10.1136/annrheumdis-2019-216557
VO 80
IS 11
A1 Lea C Berkhout
A1 Merel J l'Ami
A1 Gerrit Jan Wolbink
A1 Theo Rispens
YR 2021
UL http://ard.bmj.com/content/80/11/e172.abstract
AB